Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China
- PMID: 29145300
- PMCID: PMC5704845
- DOI: 10.1097/MD.0000000000008683
Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China
Abstract
Background: Pulse oximetry screening is a highly accurate tool for the early detection of critical congenital heart disease (CCHD) in newborn infants. As the technique is simple, noninvasive, and inexpensive, it has potentially significant benefits for developing countries. The aim of this study is to provide information for future clinical and health policy decisions by assessing the cost-effectiveness of CCHD screening in China.
Methods and findings: We developed a cohort model to evaluate the cost-effectiveness of screening all Chinese newborns annually using 3 possible screening options compared to no intervention: pulse oximetry alone, clinical assessment alone, and pulse oximetry as an adjunct to clinical assessment. We calculated the incremental cost per averted disability-adjusted life years (DALYs) in 2015 international dollars to measure cost-effectiveness. One-way sensitivity analysis and multivariate probabilistic sensitivity analysis were performed to test the robustness of the model. Of the three screening options, we found that clinical assessment is the most cost-effective strategy compared to no intervention with an incremental cost-effectiveness ratio (ICER) of Int$5,728/DALY, while pulse oximetry plus clinical assessment with the highest ICER yielded the best health outcomes. Sensitivity analysis showed that when the treatment rate increased up to 57.5%, pulse oximetry plus clinical assessment showed the best expected values among the three screening options.
Conclusion: In China, for neonatal screening for CCHD at the national level, clinical assessment was a very cost-effective preliminary choice and pulse oximetry plus clinical assessment was worth considering for the long term. Improvement in accessibility to treatment is crucial to expand the potential health benefits of screening.
Conflict of interest statement
This study is granted by National Nature Science Foundation (No.81202225) and Japan Agency for Medical Research and Development (No.27300101). We declare no conflicts of interest.
The authors report no conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5704845/bin/medi-96-e8683-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5704845/bin/medi-96-e8683-g005.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5704845/bin/medi-96-e8683-g006.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5704845/bin/medi-96-e8683-g007.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5704845/bin/medi-96-e8683-g008.gif)
Similar articles
-
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. doi: 10.3310/hta9440. Health Technol Assess. 2005. PMID: 16297355 Review.
-
Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.Health Technol Assess. 2012;16(2):v-xiii, 1-184. doi: 10.3310/hta16020. Health Technol Assess. 2012. PMID: 22284744
-
Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis.Arch Dis Child. 2012 Mar;97(3):221-6. doi: 10.1136/archdischild-2011-300564. Epub 2012 Jan 13. Arch Dis Child. 2012. PMID: 22247242
-
Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.Pediatrics. 2013 Sep;132(3):e595-603. doi: 10.1542/peds.2013-0332. Epub 2013 Aug 5. Pediatrics. 2013. PMID: 23918890 Free PMC article.
-
Neonatal pulse oximetry screening improves detecting of critical congenital heart disease.Chin Med J (Engl). 2013 Jul;126(14):2736-40. Chin Med J (Engl). 2013. PMID: 23876906 Review.
Cited by
-
An Insight into Indonesia's Challenges in Implementing Newborn Screening Programs and Their Future Implications.Children (Basel). 2023 Jul 13;10(7):1216. doi: 10.3390/children10071216. Children (Basel). 2023. PMID: 37508713 Free PMC article. Review.
-
High impact health service interventions for attainment of UHC in Africa: A systematic review.PLOS Glob Public Health. 2022 Sep 23;2(9):e0000945. doi: 10.1371/journal.pgph.0000945. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962639 Free PMC article.
-
The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review.Int J Neonatal Screen. 2020 Nov 23;6(4):94. doi: 10.3390/ijns6040094. Int J Neonatal Screen. 2020. PMID: 33238605 Free PMC article.
-
Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas.Asian Pac J Cancer Prev. 2020 Jan 1;21(1):67-73. doi: 10.31557/APJCP.2020.21.1.67. Asian Pac J Cancer Prev. 2020. PMID: 31983166 Free PMC article.
References
-
- Ministry of Health of People's Republic of China. National birth defects control and prevention report 2012. Available: http://www.gov.cn/gzdt/att/att/site1/20120912/1c6f6506c7f811bacf9301.pdf.
-
- Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation 2009;120:447–58. - PubMed
-
- Ewer AK, Middleton LJ, Furmston AT, et al. the PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011;378:785–94. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials